Yes, several anxiety medications are considered compatible with breastfeeding. The most commonly recommended options pass into breast milk at very low levels, well below the safety thresholds that pharmacologists use to evaluate risk. That said, not all anxiety medications carry the same profile, and a few factors about your baby’s age and health matter when weighing the decision.
How Drug Safety Is Measured in Breast Milk
Researchers use a metric called the Relative Infant Dose (RID) to evaluate whether a medication is safe during breastfeeding. RID represents the amount of drug your baby would receive through milk, expressed as a percentage of your weight-adjusted dose. An RID below 10% is widely accepted as the safety threshold, and most anxiety medications fall well under that line.
Think of it this way: if a drug has an RID of 1%, your baby is getting roughly 1% of the dose you’re taking (adjusted for body weight). That tiny fraction is what makes many medications workable during breastfeeding, even when detectable amounts do show up in milk.
SSRIs: The Most Studied Options
Selective serotonin reuptake inhibitors are the best-researched anxiety medications in breastfeeding mothers. Sertraline consistently comes out as a top choice. In a study published in Frontiers in Pharmacology, sertraline had an RID of just 1%, meaning an exclusively breastfed infant receives a negligible fraction of the mother’s dose. Paroxetine came in at about 2%, and citalopram at around 6%. All three fall comfortably below the 10% safety cutoff.
One detail worth knowing: sertraline and citalopram actually concentrate in breast milk at levels higher than in maternal blood (their milk-to-plasma ratios are 2.3 and 1.8, respectively). That sounds alarming, but because the overall amount transferred is so small relative to body weight, the RID stays low. Paroxetine, by contrast, stays at lower concentrations in milk than in blood, with a milk-to-plasma ratio of 0.6.
Adverse effects in infants exposed to SSRIs through breast milk are rare and generally mild when they do occur. Isolated case reports have described fussiness, decreased feeding, and sleep changes with citalopram and fluoxetine, but large-scale monitoring studies find these events are uncommon. Fluoxetine tends to be used less often during breastfeeding because it and its active byproduct linger in the body longer, which can lead to slightly higher infant exposure compared to sertraline or paroxetine.
SNRIs and Other Prescription Options
If SSRIs aren’t the right fit, duloxetine (an SNRI) has a reassuring safety profile during breastfeeding. Multiple studies have measured its RID at roughly 0.14% to 0.82%, depending on the mother’s dose and the timing of milk sampling. In one case, duloxetine was completely undetectable in the infant’s blood despite exclusive breastfeeding. In another, the baby’s plasma level was less than 1% of the mother’s.
Venlafaxine, the other commonly prescribed SNRI, transfers into milk at somewhat higher levels than duloxetine but is still used when clinically appropriate. Less data exists for buspirone, a non-SSRI anxiety medication, so it’s harder to make confident safety statements about it during lactation.
Benzodiazepines: Lower Risk Than Expected
Benzodiazepines have a more cautious reputation, but the data is more reassuring than many parents expect. A Motherisk follow-up study found no signs of central nervous system depression (sleepiness, poor latching, limpness, or failure to wake for feeds) in 98.4% of infants exposed to benzodiazepines through breast milk. That rate was essentially identical to a control group of infants whose mothers took only acetaminophen.
The researchers concluded that benzodiazepine use was compatible with breastfeeding. The main precaution is to avoid stacking multiple sedating medications at once, since combining them raises the chance of infant drowsiness. Short-acting benzodiazepines are generally preferred over long-acting ones, because they clear the body faster and accumulate less in milk over time.
Your Baby’s Age and Health Matter
Not all babies process medications at the same rate. Premature infants, newborns in the first few weeks of life, and babies with kidney or liver problems are the most vulnerable to any drug that comes through breast milk. Their organs are still maturing, so they clear medications more slowly.
There’s a practical silver lining in the early days, though: during the first three to four days after delivery, your body produces colostrum in small volumes, so the total amount of medication transferred is very low regardless of what you’re taking. By the time your milk supply increases, your baby has already had a few days of metabolic development.
By six months, a healthy baby’s liver and kidneys are significantly more efficient at breaking down trace amounts of medication. This is why the risk profile of most anxiety drugs improves as your baby gets older.
Timing Your Dose Around Feedings
Most medications reach their peak concentration in breast milk at a predictable time after you take them. Feeding your baby just before taking your dose, or waiting until the drug has passed its peak in your system, can reduce the amount your infant is exposed to in a given session. This strategy is especially useful for medications with shorter half-lives, where levels rise and fall more sharply.
For SSRIs like sertraline, which are typically taken once daily, some mothers find it practical to take their dose right after a feeding or before their baby’s longest stretch of sleep. The reduction in exposure from timing alone is modest, since these drugs are already transferred in very small amounts, but it’s a simple step that adds an extra margin of comfort.
Therapy and Non-Drug Approaches
Behavioral interventions can work alongside medication or, for milder anxiety, as a standalone approach. A systematic review in the International Breastfeeding Journal found that twelve separate studies showed statistically significant improvements in both maternal mental health and breastfeeding outcomes from non-drug interventions. Effective approaches included cognitive-behavioral therapy, relaxation training, psychoeducational group programs, motivational interviewing, and peer support with home visits.
The interventions that worked best combined professional guidance with peer support across multiple settings, such as a combination of clinic visits, home check-ins, and community resources sustained throughout the postpartum period. For many mothers, pairing a low-dose medication with therapy produces better results than either approach alone.
What to Watch For in Your Baby
Regardless of which medication you take, keeping an eye on your baby’s behavior gives you early warning if something isn’t agreeing with them. The signs to look for include:
- Feeding changes: decreased appetite, difficulty latching, or refusing the breast
- Sleep disruption: unusual drowsiness, difficulty waking for feeds, or increased restlessness
- Behavioral shifts: excessive crying, irritability, or unusual excitement
- Physical signs: decreased muscle tone (feeling “floppy”), tremors, or poor weight gain
These side effects are reported in a small minority of cases and are typically mild and reversible. In large monitoring studies, the vast majority of breastfed infants exposed to maternal anxiety medications show no detectable adverse effects. Still, noticing a pattern early means you and your prescriber can adjust the medication or dose before it becomes a real problem.